Lawyer and politician, Lim Tean has posted on his Facebook page that there is a fake WhatsApp message that has been circulating on social media about the speakers for the rally this coming 26 Jan.

The WhatsApp message had claimed that Dr Tan Cheng Bock , Lee Hsien Yang and Dr Lee Wei Ling will be speaking at the Abuse Of Process Rally held at Hong Lim Park, on 26 January.

Calling the message as “despicable fake news” and being spread by Internet Brigades of the People’s Action Party, Mr Lim said that it is untrue and he had never made such a claim.

“It is no doubt the work of the PAP IBs who are up to their usual dirty tricks dishing out fake news.” wrote Mr Lim.

He went on to state, “these despicable IBs will be trying to sow disinformation amongst Singaporeans with fake news via WhatsApp and other Social Media platforms”, leading up to the next General Election. (To read about PAP’s internet brigade, visit the series of articles TOC did back in 2014 here.)

“I advise all to be eternally vigilant against these enemies of our Nation.” warns Mr Lim.

He shared that the public will be informed in due course of the line-up of Speakers for the rally.

The rally was earlier announced by Mr Lim on Wednesday which is held in light of the countersuit by Leong Sze Hian, a veteran blogger and financial consultant, against Prime Minister Lee Hsien Loong for the abuse of the process of the Court. Leong filed a countersuit after he was sued by PM Lee for sharing a link of an article on Facebook for defamation.

While the People’s Action Party government is coming up with a new legislation to deal with deliberate online falsehoods, it seems unlikely for the legislation to act upon such falsehoods. It has been seen on a couple of occasions how the government sidesteps on transgressions that is against the opposition or civil activists’ interest. With the actions of the Attorney General in recent days, it is even more doubtful that the new law will put an end to such behaviors against the critics of the government.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

Singapore increased by three ranks to 151st place for World Press Freedom Index

Singapore’s World Press Freedom Index increased by three ranks this year, as…

Certis APO kicking PMD rider; LTA says that it does not condone any behaviour that deviates from the established rules of engagement

Commenting on the incident where a Certis Cisco Auxillary Police Officer kicked…

AG’s definition of “sub judice” called into question

Mr Kenneth Jeyaretnam has questioned what he described as the Attorney General’s…

新加坡与国际机构紧密合作 研发新疫苗对付新冠

杜克-NUS医学院传染病研究主任王林发称,新加坡正与国际机构流行病防范创新联盟(CEPI)密切合作,研发对付新冠病毒疫苗。 上周,CEPI召集各地专家,尽快开发和研制新疫苗以对抗新冠病毒。而到了本周将会挑选出适合的团队,并给予至少16周的时间来接种疫苗,随后再决定是否准备好进入第一阶段的临床试验。 王林发在记者会上指出,“我们正试图说服他们在新加坡进行第一阶段的临床试验。” 尽管加快速度研发疫苗,但专门研究传染病的许立阳副教授表示,在研发疫苗上可能会需要更多时间,至少需要一年的时间准备疫苗上市。 “这是因为疫苗的研发需要经过安全有效的监控,即使在此次疫情爆发后,最后能够如愿达到很好的控制,但仍然非常感恩能够研发有效疫苗,以应对未来再度爆发”,他表示。 自疫情爆发以来,新加坡已出现45例确诊病例,成为中国以外,续日本后确诊病例最多的国家。 赖建文:部分患者使用HIV药物迅速现反应,但也有持续恶化的现象 此外,《亚洲新闻台》报道,参与临床研究的陈笃生医院国家传染病中心传染病研究与培训部主任赖建文指出,在对抗病毒时,会给予部分患者使用人类免疫缺陷病毒(HIV)的药物。 他解释,当这些患者使用HIV药物时,医生也会观察他们的氧气水平是否提高,发烧症状是否减退,以及他们的拭子是否对新冠病毒呈阴性。 “由于使用的患者人数较少,而且其他的国家使用的样本数也较少,加上没有详细的数据,很难确定其效用,但在我们的经验中,能够在部分患者看到非常迅速的效应。同时我们也看到有些人持续恶化的现象。” 他续指,专家目前正积极研究开发,同时也正讨论研究方案,其研究方案应包含何种患者;是否应对无任何症状的呈阳性结果的患者给予含有副作用的潜在药物;药物的种类等等,也在其争议之中。 他补充道,目前有种药物对于中东呼吸综合征冠状病毒(MERS-CoV)以及新型冠状病毒具有“良好的活性”,并曾用于动物以及测试埃博拉(Ebola)病毒的实验中,但它尚未适用于治疗新型冠状病毒。…